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Arnold Chiari Malformation (ACM) is defined as a condition where part of the cerebellar tissue herniates into the
cervical canal toward the medulla and spinal cord resulting in a number of clinical manifestations. Type I ACM
consists of variable displacement of the medulla throughout the formamen magnum into the cervical canal, with
prominent cerebellar herniation.
Type I ACM is characterized by symptoms related to the compression of craniovertebral junction, including ataxia,
dysphagia, nistagmus, headache, dizziness, and sleep disordered breathing. We report a case of a life-long non-
smoker, 54 years old woman who presented these symptoms associated with bronchiectasis secondary to recurrent
inhalation pneumonia, hypercapnic respiratory failure, and central sleep apnea (CSA).
CSA was first unsuccessfully treated with nocturnal c-PAP. The subsequent treatment with low flow oxygen led to
breathing pattern stabilization with resolution of CSA and related clinical symptoms during sleep. We suggest that
in patients with type I ACM the presence of pulmonary manifestations aggravating other respiratory disturbances
including sleep disordered breathing (SDB) should be actively investigated. The early diagnosis is desirable in order
to avoid serious and/or poorly reversible damages.
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Arnold-Chiari malformation (ACM) is a complex syn-
drome in which the brainstem medulla, and the cerebel-
lar tonsils and vermis herniate throughout the foramen
magnum [1]. Type I ACM is defined by the herniation
of only the medulla and cerebellar tonsils whereas type
II ACM is also characterized by caudal displacement of
the cerebellar vermis [2]. The main symptoms include
ataxia, dizziness, chronic headache, nystagmus, twitching,
oropharyngeal dysfunction, recurrent respiratory infections,
paresthesia, pyramidal signs and sleep disordered breathing
(SDB) encompassing a number of sleep disturbances
characterized by apneas or hypopneas, intermittent hyp-
oxaemia, microarousals, and disruption of sleep continuity* Correspondence: raffaelemd@hotmail.it
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reproduction in any medium, provided the or[3]. All these disturbances are related to the compres-
sion of respiratory centers and their neural pathways
related to herniation [4]. We report a case of type I ACM
with recurrent aspiration-induced pneumonia, secondary
bronchiectasis, respiratory failure, and central sleep apneas.Case report
A 54-years-old woman with type I ACM (BMI 19.2 kg/m2,
neck and waist circumference 34 and 65 cm respectively,
Mallampati score 2), was referred to our Respiratory Unit
with a history of chronic cough and purulent sputum,
fever, intense dyspnoea (MRC dyspnoea scale 4), hoarse-
ness, excessive daytime sleepiness (Epworth Sleepiness
Scale 14), involuntary naps, snoring, nocturia and morning
headaches. These respiratory symptoms had been present
for more than five years. She referred six hospital
admissions because of inhalation pneumonia in the last
five years. Physical examination revealed normal pulse rate
(66 per minute), high respiratory rate (24 per minute),l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 2 Bronchiectasis. The arrows show cylindrical
bronchiectasis spread to both lungs appearing as “signet ring”.
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saturation (SpO2 90%). Cardiac auscultation was normal,
whereas pulmonary auscultation revealed diffuse rales
in both lungs, basal and bilateral crackles. Neurologic
examination showed nistagmus, tongue twitching, dys-
arthria, dizziness, walking ataxia, severe dysphagia and
persistent bilateral abductor vocal cord paralysis. Rou-
tine blood tests gave normal results apart from high
level of C-reactive protein (5.68 mg/dl), ESR (64 mm)
and low serum albumin (3.3 g/dl). Cervico-medullary
magnetic resonance imaging showed cerebellar tonsils
herniation through the foramen magnum to the level of
C2 vertebra, basilar imprint and bulbar compression
[Figure 1]. Chest X-Ray showed no pulmonary consoli-
dation whereas several cylindrical bronchiectasis of both
lungs were seen on chest CT [Figure 2]. All causes for
congenital bronchiectasis were excluded. The patient
had no family history of cystic fibrosis, α1-antitrypsin
deficiency, or other conditions that predispose to the
onset of secondary bronchiectasis such as tuberculosis
or infection during childhood. Sputum smear for acid
fast bacilli and Quantiferon-TB test were negative. Ar-
terial PO2, PCO2 and pH were 58, 50 mmHg, and
7.43 respectively. Pulmonary function test revealed
volumes within normal limits [FVC 2,13 L (88% pred),
FEV11,67 L (93% pred), FEV1/FVC ratio 0.78. The diffu-
sion capacity of the lung for CO (DLco): 103% pred;
DLco/VA 1.47 (110% pred.). Because of excessive day-
time sleepiness, heavy snoring and hypercapnic respira-
tory failure we performed overnight polysomnography
in room air, after titration of c-PAP (9 cm H2O),
and during nasal oxygen administration (FiO2 0,24%) 
Figure 1 Sagittal craniocervical magnetic resonance imaging
section. The arrow shows cerebellar tonsils herniation trough the
foramen magnum until the second cervical vertebra and
bulbar compression.overnight. These consisted of recording of airflow, pulse
oximetry, thoracic and abdominal movements, heart
rate, body position, snoring, legs positions and two-
channel electroencephalogram. Apneas, hypopneas, and
apnea-hypopnea index (AHI) were defined according to
current criteria [5,6]. Polysomnography in room air
revealed an AHI of 42 events h-1 with several prolonged
episodes of Central Sleep Apneas (CSA) and some
events of obstructive sleep apnea (OSA) and an average
of arterial saturation of 89% [Figure 3]. The patient did
not show any cardiovascular comorbidity (normal echo-
cardiogram, no signs of pulmonary hypertension or
cardiac arrhythmias).
After titration of c-PAP , polysomnography showed a
decrease in AHI from 42 to 22 events h-1 and mean of
SpO2 was 92%. Registration during nasal oxygen admin-
istration revealed a reduction in the number of both
CSA and OSA allowing a significant improvement of
AHI along with apnoea duration; mean SpO2 was 96%
[Table 1]. Capnography was performed to evaluate
changes in nocturnal hypercapnia. Average pCO2 was 52
mmHg (range 44–56 mmHg). Average SpO2 was 89%.
During low-flow nocturnal oxygen (FiO2 0,24%) pCO2
was 57 mmHg (range 53-63 mmHg); average SpO2 was
96%. During wakefulness the patient returned to be
hypercapnic with values similar to baseline, then worsening
of average pCO2 was only partial and transitory. The
patient did not take any drug known to alter the sleep
pattern. Administration of broad-spectrum antibiotics
(piperacillin/tazobactam 4,5 g/t.i.d and Ciprofloxacin
500 mg b.i.d.] was started, and corticosteroid (prednis-
one 25 mg/die) was administered for 7 days. During fol-
low up examination, the patient was clinically improved,
with regression of cough, sputum, improvement in re-
spiratory symptoms and daytime sleepiness (ESS 5), but




Figure 3 Central sleep apnoeas. Flow, chest and abdomen pattern during central sleep apnoeas.
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This case presentation offers the opportunity to specu-
late about the occurrence of respiratory involvement and
its mechanisms in patients with type I ACM. Sleep
disordered breathing is associated with ACM and gener-
ally ascribed to two types of abnormalities: upper airway
dysfunctionwhich is associated with obstructive apneas,
and abnormalities of respiratory controlwhich is presum-
ably involved in the pathophisiology of central sleep
apneas [4,7]. The latter are characterized by transient
cessation of neural respiratory output during sleep
resulting in poor ventilation and impaired gas exchange
[8]. The transient cessation of respiratory drive could be
due to: firstly, an outright defect in respiratory drive;Table 1 Polysomnographic data at baseline, during C-PAP
breathing, and during continuous oxygen administration
Polysomnographical data
Baseline C-PAP FiO2 24%
Polysomnography
Total Sleep Time 7 h 03 m 7 h 40 m 7 h 30 m
Sleep onset latency 18.8 m 21.3 m 18.8 m
% Sleep efficiency 89 90 92
% Slow Wave Sleep 27 31 33
% REM 19 22 25
Respiratory Events
AHI 42 22 1
AC 125 63 3
AO 1 9 1
AM 9 0 0
HI 186 77 1
CH 175 72 3
OH 11 5 0
O2 saturation 89% 92% 96%
ODI 43 15.7 3.0
cT90 30% 21% 0%
Nadir SaO2 82 84 90
AHI Apnoea/hypopnoea index, AC Central apnea, AO Obstructive apnoea, AM
Mixed apnoea, HI Hypopnoea; CH Central Hypopnoea, OH Obstructive
Hypopnoea, ODI Oxygen Desaturation Index, cT90 percentage of sleep time
spent with SaO2 below the threshold of 90%; SaO2: arterial saturation; REM
Rapid Eye Movements.secondly, a transient instability in an otherwise intact
respiratory control system; and thirdly, a transient active
inhibition of respiratory motor drive [9]. In addition,
patients may be either hypercapnic or non-hypercapnic.
The hypercapnic group, which includes patients with
central hypoventilation and a number of neurological
syndromes, is consistent with the first pathophysio-
logical mechanism. The non-hypercapnic group includes
patients with idiopathic hyperventilation and periodic
breathing. Pathophysiologically this group is consistent
with the second or third mechanism. These patients typic-
ally have a low or normal awake pCO2 [10]. In OSA,
pharyngeal anatomy, upper airway muscles responsiveness
during sleep, arousal threshold, and loop gain may all con-
tribute to the occurrence of apnea presence and severity
of central apneas. During sleep reflex muscles activation is
reduced and if the airway anatomy is quite deficient will
likely lead to substantial or complete airflow obstruction,
yielding a hypopnoea or apnea [11]. The patient had the
hypercanic form of CSA The risk of apnoea resulted
from both obstructive (short neck, limited mobility of
soft palate and tongue) and central causes. Central
causes may include: 1) compromised vascular supply to
the brainstem due to compression; 2) insensitivity of
peripheral chemo-receptors, due to brainstem involve-
ment; 3) direct compression of the respiratory centre
[11]. In our case both central and obstructive apneas
was confirmed with polysomnography. Nasal c-PAP (9
cmH2O), after proper titration, was partially effective
in improving the AHI and apnea duration, but limited
compliance to the treatment. Polysomnography was
repeated during low flow oxygen administration
resulting in a significant reduction in both number and
duration of CSA and an increase in SpO2 (average apnea
duration in baseline condition 16.5 seconds; after low
flow oxygen administration 11.2 sec). The use of supple-
mental low flow oxygen, as mentioned in another case re-
port of a patient with primary alveolar hypoventilation,
chronic hypercapnia and CSA, led to a decrease in num-
ber and duration of central apneas [11,12]. The improve-
ment produced by oxygen may have been due to the fact
that the patient had no demonstrable ventilatory response
to hypoxia during wakefulness, and therefore may have
developed hypoxic brainstem depression during sleep. The
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may be beneficial in patients with primary alveolar
hypoventilation and CSA leading to significant im-
provement of SDB and all related symptoms [12].
Oxygen administration during sleep has been associated
with reproducible reduction of AHI [Table 1] Type I
ACM, whether alone or in combination with syringomye-
lia, can cause a great number of progressive disorders such
as dysphagia, alveolar hypoventilation, inhalation pneumo-
nia, and respiratory failure [13]. In our patient recurrent
aspirations with consequent inhalation pneumonia oc-
curred. The most important mechanism of recurrent as-
piration pneumonia was dysphagia [14]. The alterations
underlying dysphagia are stretch injury to the lower cra-
nial nerves caused by caudal displacement of the medulla
or compression of the swallowing centres in the brainstem
[15]. Probably the pressure determined by the cerebellar
tonsils on the hypoglossal nuclei and other swallowing
centres located in the medulla is tough to be the leading
cause of the dysphagia [16]. Recurrent aspirations result in
several respiratory infections which may lead both to post-
inflammatory bronchiectasis and lung parenchymal dam-
age, causing chronic respiratory failure (CRF) [17,18].
Respiratory failure as the early manifestation in type I
ACM is uncommon and, generally, is the result of
postoperative conditions [19]. Cylindrical bronchiectasis,
as documented in Figure 2, have become a source of
repeated infections with recurrent exacerbations of CRF,
chronic cough, intense dyspnoea and fever treated with
antibiotics and often requiring hospitalization [20]. Re-
spiratory failure probably has been caused not only by
neuromuscular disorders affecting the diaphragm due to
compression of neural centers in the brainstem, but also
resulted from swallowing disturbances and dysphagia fur-
ther complicated by recurrent aspiration pneumonia.
Conclusions
This case report suggests that a neurologic cause can
always be considered for recurrent aspiration pneumonia
and progressive dysphagia, even in absence of prominent
signs and symptoms. The high prevalence of sleep apnoea
syndrome in patients with neurological disorders indicates
that respiratory disturbances during sleep should be sys-
tematically screened even in ACM patients, in order to
prevent nocturnal respiratory failure and all the risks
associated with nocturnal intermittent hypoxia. In sum-
mary, central sleep apnoea can be the typical manifest-
ation of ACM and may be a life-threatening condition.
The severity of CSA may explain the reported increased
incidence of death during sleep in ACM patients [11].
Using a low flow oxygen during sleep, even in hypercanic
patients, avoids mechanical ventilation that is often not
well tolerated. Oxygen administration allows to solve
CSA and all related cerebrovascular risks associatedwith nocturnal respiratory failure and sleep fragmenta-
tion, improving quality of life. Oxygen therapy can
generate potentially deprimental effects. The most
relevant of these is the worsening of hypercapnia, which is
mediated by mechanisms such as hypoventilation and
ventilation-perfusion redistribution. Particularly sleep itself
generates ventilatory alterations that include an increase
in airway resistance and decreased sensitivity of respira-
tory centers. Arterial blood gases samples should be peri-
odically taken at awakening to assess pCO2 in order to
prevent hypoventilation from the oxygen therapy [21,22].
The availability of further clinical studies for the treatment
of CSA with low flow oxygen in hypercapnic patients is
desiderable to avoid serious and irreversible damage.
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